Nicholas Martinez Selected Research

ferric maltol

3/2022	Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
1/2022	Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas Martinez Research Topics

Disease

2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2022 - 01/2022
2	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 03/2022 - 01/2022
1	Carcinoma (Carcinomatosis) 08/2016
1	Ulcerative Colitis 05/2015
1	Crohn Disease (Crohn's Disease) 05/2015
1	Pancreatitis 04/2013
1	Hemorrhage 04/2013
1	Cholestasis 04/2013

Drug/Important Bio-Agent (IBA)

2	ferric carboxymaltoseIBA 03/2022 - 01/2022
2	ferric maltolIBA 03/2022 - 01/2022
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	IronIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 08/2016
1	Biological ProductsIBA 05/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2013
1	Sphincterotomy 04/2013
1	Stents 04/2013